Ogenix chooses Inno3Med to prospect the market in France regarding the TCOT technology (EPIFLO)

OGENIX, an American company based in OHIO, has asked  Inno3MeD to prospect the French market and promote  EPIFLO, a unique device that heals chronic wounds faster,  using the technology of Transdermal Continuous Oxygen Therapy (TCOT)

“We know France might be a difficult market to enter, so we trust our cooperation with Inno3Med will help us achieve our goal”, said Craig DAVIS, OGENIX Managing Director